Oxfordshire Clinical Commissioning Group
Formulary
 
back
16 Off-label use / Unlicensed / Non-BNF
16-01 Other items

Anal Irrigation Systems
Formulary

Suitable for prescribing in primary care following specialist recommendation in line with Clinical Commissioning Policy 248.


Amber Continuation  View adult BNF  View SPC online  View childrens BNF
Aquadeks
Restricted

For cystic fibrosis in children.

APCO March 2012.


Restricted Drug Brown View adult BNF  View SPC online  View childrens BNF
Botulinum Toxin A Xeomin®
Formulary

For treating chronic sialorrhoea in line with NICE TA605.

Also see Clinical Commissioning Policy 254A.

APCO November 2019.

Link  NICE TA605: Xeomin (botulinum neurotoxin type A) for treating chronic sialorrhoea
 

Red View adult BNF  View SPC online  View childrens BNF
Cerliponase alpha Brineura®
Formulary

For treating neuronal ceroid lipofuscinosis type 2. Funded by specialised commissioning.

APCO January 2020.

Link  NICE HST12: Cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2
 

Red View adult BNF  View SPC online  View childrens BNF
Dibotermin alfa InductOs®
Formulary

For primary and revision spinal fusion.

Funded by specialised commissioning.

APCO May 2018.


Red View adult BNF  View SPC online  View childrens BNF
Gastrografin
Formulary

For short bile obstruction.

APCO May 2018.


Red View adult BNF  View SPC online  View childrens BNF
Holoclar
Formulary

For treating limbal stem cell deficiency after eye burns as per NICE TA467.

NB. The responsible commissioning body is still to be confirmed for this treatment.

APCO September 2017. 

Link  NICE TA467: Holoclar for treating limbal stem cell deficiency after eye burns
 

Red View adult BNF  View SPC online  View childrens BNF
Intratympanic methylprednisolone  Sodium Succinate
Formulary

For sensorineural hearing loss. Agreed at May MMTC.

APCO July 2019.


Red View adult BNF  View SPC online  View childrens BNF
Lanadelumab Takhzyro®
Formulary

For preventing recurrent attacks of hereditary angioedema as per NICE TA606.

Funded by specialised commissioning.

APCO November 2019.

 

Link  NICE TA606: Lanadelumab for preventing recurrent attacks of hereditary angioedema
 

Red View adult BNF  View SPC online  View childrens BNF
Mydrane
Formulary
Secondary care use only.

APCO September 2017. 


Red View adult BNF  View SPC online  View childrens BNF
Strimvelis
Formulary

Strimvelis for treating adenosine deaminase deficiency–severe combined immunodeficiency as per NICE HST7.

APCO March 2018.

Link  NICE HST7: Strimvelis for treating adenosine deaminase deficiency–severe combined immunodeficiency
 

Red View adult BNF  View SPC online  View childrens BNF
Sulphur Hexafluoride Sonovue
Restricted

For enhancement of tissues/ blood vessels/ fluid on an ultrasound scan for children. Restricted to radiology.


Restricted Drug Red View adult BNF  View SPC online  View childrens BNF
Tacrolimus suppositories
Formulary

Specialist prescribing only approved at MMTC May 2019.

APCO July 2019.

 


Red View adult BNF  View SPC online  View childrens BNF
Voretigene Neparvovec  Luxturna®
Formulary

For treating inherited retinal dystrophies caused by RPE65 gene mutations in line with HST11.

Funded by specialised commissioning.

APCO November 2019.

Link  HST11: Voretigene neparvovec for treating inherited retinal dystrophies caused by RPE65 gene mutations
 

Red View adult BNF  View SPC online  View childrens BNF
Abnoba-viscum (Mistletoe extract)
Non Formulary

For the treatment of malignant melanoma. See Clinical Commissioning Policy 2C.

Priorities Committee March 2009.


Black View adult BNF  View SPC online  View childrens BNF
Actipatch®
Non Formulary

Lack of good evidence for effectiveness.

APCO September 2018.


Black View adult BNF  View SPC online  View childrens BNF
Dehydroepiandrosterone DHEAS
Non Formulary

Not recommended following the removal of the adrenal gland.

APCO July 2004.


Black View adult BNF  View SPC online  View childrens BNF
Depigmenting Pigmanorm®
Non Formulary

Unlicensed. Not recommended in line with Policy No 6i (TVPC16)  Aesthetic treatments for adults and children.

APCO May 2019.


Black View adult BNF  View SPC online  View childrens BNF
Gamolenic acid
Non Formulary

For mastalgia and atopic eczema. 

NB. Product licence withdrawn October 2002.


Black View adult BNF  View SPC online  View childrens BNF
Pentosan Polysulphate Capsules 50 mg Elmiron®
Non Formulary

Not recommended as no cost-efficacy data.

APCO July 2010.


Black View adult BNF  View SPC online  View childrens BNF
RESPeRATE® device
Non Formulary

For hypertension, routine provision of relaxation therapies by primary care teams is not currently recommended within NICE CG127.

APCO March 2012.

Link  NICE CG127: Hypertension in adults: diagnosis and management
 

Black View adult BNF  View SPC online  View childrens BNF
Sodium Hyaluronate 800mg/50mL (1.6%), Sodium Chondroitin Sulfate 1g/50mL (2%) Ialuril®
Non Formulary

Medical device for urinary tract conditions.

APCO May 2014.


Black View adult BNF  View SPC online  View childrens BNF
Souvenaid®
Non Formulary

Some evidence of improved memory but limited to very early disease only and no improvement in cognition demonstrated. Can be purchased OTC as per Clinical Commissioning Policy 88D.

APCO January 2013.


Black View adult BNF  View SPC online  View childrens BNF
Virulite Cold Sore Machine
Non Formulary

Not recommended for use. Can be purchased OTC.

APCO March 2008.


Black View adult BNF  View SPC online  View childrens BNF
Naltrexone
Non Formulary

Not recommended for multiple sclerosis (low dose naltrexone).

APCO March 2005.


Black View adult BNF  View SPC online  View childrens BNF
Timolol Topical
Non Formulary

Not recommended for use as limited evidence and may be more cosmetic or superficial in majority of cases.

APCO January 2016.


Black View adult BNF  View SPC online  View childrens BNF